EU GMP Annex 1 and Parenteral Packaging: A Quality-by-Design Approach to Sterile Manufacturing

The recent revisions to EU GMP Annex 1 have prompted pharmaceutical companies to shift towards a Quality by Design approach in manufacturing and parenteral packaging, placing a strong emphasis on contamination control. Delve into our whitepaper to explore the impacts of this updated legislation and discover how to maintain compliance by selecting packaging components that meet the highest industry standards.